Detalles de la búsqueda
1.
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.
Cell
; 173(2): 400-416.e11, 2018 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29625055
2.
Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data.
BMC Bioinformatics
; 24(1): 298, 2023 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481512
3.
Quantile Index Biomarkers Based on Single-Cell Expression Data.
Lab Invest
; 103(8): 100158, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37088463
4.
Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer.
Breast Cancer Res Treat
; 184(3): 689-698, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32880016
5.
Comparative analysis of differentially abundant proteins quantified by LC-MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples.
Clin Proteomics
; 17(1): 40, 2020 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33292179
6.
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.
Breast Cancer Res Treat
; 177(1): 77-91, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165373
7.
Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.
Mod Pathol
; 29(10): 1143-54, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27312066
8.
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.
Breast Cancer Res
; 15(5): R73, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24004716
9.
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.
JCO Precis Oncol
; 7: e2100498, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36652667
10.
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
Breast Cancer Res
; 14(5): R130, 2012 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23036105
11.
Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer.
Cancers (Basel)
; 14(2)2022 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053472
12.
Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues.
J Proteome Res
; 10(3): 1323-32, 2011 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21155598
13.
DW4TR: A Data Warehouse for Translational Research.
J Biomed Inform
; 44(6): 1004-19, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21872681
14.
Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers.
Cancer Biol Ther
; 21(7): 629-636, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378445
15.
PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.
Sci Rep
; 9(1): 7956, 2019 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31138829
16.
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
Clin Cancer Res
; 24(24): 6355-6366, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30097435
17.
Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population.
Mil Med
; 182(11): e1851-e1858, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29087852
18.
Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.
PLoS One
; 10(6): e0129500, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26098961
19.
Procedure for immunocytochemical detection of P16INK4A antigen in thin-layer, liquid-based specimens.
Acta Cytol
; 46(1): 25-9, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-11843554
20.
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
J Clin Oncol
; 29(18): 2448-58, 2011 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-21576635